Johnson & Johnson stock gains on MONARCH QUEST 3 clearance
Published on 08/17/2026 at 17:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson (US4781601046) stock was quoted at $260.61 on August 17, 2026, after a 0.10% move in one live market snapshot, while the 12-month range stood at $274.90 to $173.33 and market cap at $627.41 billion. MarketScreener's report on MONARCH QUEST 3 said Johnson & Johnson announced U.S. 510(k) clearance for the MONARCH Platform update on August 17, 2026.
Regulatory clearance lands
The latest product update adds another data point to a stock that already changed hands at $259.73 bid and $259.98 ask at 2:40 p.m. EDT on August 17, 2026. A separate market snapshot put the opening print at $260.44 and the current dividend yield at 2.06%, keeping the shares anchored in a narrow band around the $260 level.
For investors, the bigger backdrop still comes from the second quarter of 2026, when Johnson & Johnson reported $25.31 billion in revenue and $2.90 in EPS, both above consensus in the cited coverage. Revenue rose 6.6% year over year, while the full-year 2026 EPS guide stayed at $11.60 to $11.75.
Guidance still matters
The guidance band implies management is still aiming for adjusted earnings growth in 2026, and the consensus target price quoted in the same market data set was $268.22. That leaves the stock trading below the average target even after its 12-month high of $274.90 and a 1st Jan change of 25.57% in the cited real-time snapshot.
Market positioning also remains part of the story. One filing-based market note said institutional investors collectively own 69.55% of the stock, while another cited 64 consecutive years of dividend increases and a quarterly payout of $1.34 per share.
MONARCH in brief
MONARCH QUEST 3 is a software update for the MONARCH Platform, a robotically assisted bronchoscopy system used in early lung-cancer procedures. The release describes AI-powered nodule segmentation and a new 3D Compass overlay as part of the update.
Shares and yield
Johnson & Johnson shares remain tied to income as much as growth, with a cited annualized dividend of $5.36 per share and a yield of 2.06% in the latest market snapshot. The stock was last quoted at $260.61 in the same session.
Fact box
Company: Johnson & Johnson
ISIN: US4781601046
Ticker: JNJ
Exchange: NYSE
Sector / Industry: Healthcare / Pharmaceuticals
Index membership: Dow Jones Industrial Average
Market cap: $627.41 billion
Price: $260.61
Price as of: August 17, 2026, 9:56 a.m. EDT
